HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,247 | -10.8% | 11,833 | 0.0% | 0.00% | – |
| Q2 2023 | $13,727 | -55.1% | 11,833 | -41.5% | 0.00% | – |
| Q1 2023 | $30,557 | -72.4% | 20,237 | -54.4% | 0.00% | – |
| Q4 2022 | $110,863 | -42.3% | 44,345 | -2.6% | 0.00% | – |
| Q3 2022 | $192,000 | -7.7% | 45,538 | -38.7% | 0.00% | – |
| Q2 2022 | $208,000 | -50.2% | 74,347 | +1.5% | 0.00% | – |
| Q1 2022 | $418,000 | -36.5% | 73,233 | +1.6% | 0.00% | – |
| Q4 2021 | $658,000 | -14.3% | 72,046 | +0.3% | 0.00% | – |
| Q3 2021 | $768,000 | -7.1% | 71,825 | +34.8% | 0.00% | – |
| Q2 2021 | $827,000 | -4.3% | 53,298 | 0.0% | 0.00% | – |
| Q1 2021 | $864,000 | -22.6% | 53,298 | +1.0% | 0.00% | – |
| Q4 2020 | $1,116,000 | +42.5% | 52,766 | -0.2% | 0.00% | – |
| Q3 2020 | $783,000 | -6.2% | 52,882 | -6.8% | 0.00% | – |
| Q2 2020 | $835,000 | +65.3% | 56,710 | +31.6% | 0.00% | – |
| Q1 2020 | $505,000 | -54.0% | 43,083 | -7.9% | 0.00% | -100.0% |
| Q4 2019 | $1,099,000 | +45.8% | 46,785 | +14.8% | 0.00% | – |
| Q3 2019 | $754,000 | +38.9% | 40,740 | +39.6% | 0.00% | – |
| Q2 2019 | $543,000 | -20.1% | 29,184 | +4.8% | 0.00% | – |
| Q1 2019 | $680,000 | -5.0% | 27,852 | +1.0% | 0.00% | -100.0% |
| Q4 2018 | $716,000 | -12.6% | 27,564 | +6.5% | 0.00% | 0.0% |
| Q3 2018 | $819,000 | +104.8% | 25,885 | +151.7% | 0.00% | – |
| Q2 2018 | $400,000 | +44.4% | 10,286 | +2.3% | 0.00% | – |
| Q1 2018 | $277,000 | +33.2% | 10,057 | -11.6% | 0.00% | – |
| Q4 2017 | $208,000 | +11.8% | 11,372 | -1.9% | 0.00% | – |
| Q3 2017 | $186,000 | +18.5% | 11,590 | +2.1% | 0.00% | – |
| Q2 2017 | $157,000 | +15.4% | 11,354 | +26.6% | 0.00% | – |
| Q1 2017 | $136,000 | +33.3% | 8,971 | +13.9% | 0.00% | – |
| Q4 2016 | $102,000 | +54.5% | 7,873 | +103.3% | 0.00% | – |
| Q3 2016 | $66,000 | -12.0% | 3,873 | -8.0% | 0.00% | – |
| Q2 2016 | $75,000 | -9.6% | 4,211 | 0.0% | 0.00% | – |
| Q1 2016 | $83,000 | -29.7% | 4,211 | -1.8% | 0.00% | – |
| Q4 2015 | $118,000 | +24.2% | 4,290 | 0.0% | 0.00% | – |
| Q3 2015 | $95,000 | -26.9% | 4,290 | 0.0% | 0.00% | – |
| Q2 2015 | $130,000 | – | 4,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |